Healthcare -
Biotechnology - NASDAQ - US
$ 4.065
-2.43 %
$ 29.7 M
Market Cap
-0.37
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Kezar Life Sciences, Inc.
| Net Income | -83.7 M |
| Depreciation & Amortization | 1.04 M |
| Capital Expenditures | -29 K |
| Stock-Based Compensation | 13 M |
| Change in Working Capital | -1.3 M |
| Others | -1.38 M |
| Free Cash Flow | -74.2 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||
| Net Income | (83.7) | (101.9) | (68.2) | (54.6) | (41.7) | (35.1) | (23.2) | (8.5) | (9.0) |
| Depreciation & Amortization | 1.0 | 1.1 | 1.0 | 1.5 | 1.5 | 1.3 | 0.7 | 0.2 | 0.2 |
| Deferred Income Tax | 0 | 0 | 0 | 1.8 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 13.0 | 18.1 | 14.0 | 7.6 | 4.9 | 4.0 | 2.0 | 0.2 | 0.1 |
| Other Operating Activities | (3.2) | (3.7) | (1.2) | 91 K | 0.3 | (1.0) | (0.4) | 0.5 | 1.0 |
| Change in Working Capital | (1.3) | 4.7 | (4.5) | 1.2 | (2.0) | 0.9 | 62 K | 30 K | (1.1) |
| Cash From Operations | (74.2) | (81.6) | (58.8) | (42.4) | (36.9) | (29.9) | (20.8) | (8.1) | (9.8) |
| INVESTING CASH FLOW | |||||||||
| Capital Expenditures | 29 K | (1.8) | (1.6) | (0.3) | (0.2) | (0.6) | (1.1) | (0.4) | (0.1) |
| Other Items | 80.5 | 77.9 | (89.8) | (28.1) | (56.3) | 21.0 | (82.8) | 0 | 0 |
| Cash From Investing Activities | 80.4 | 76.0 | (91.4) | (28.4) | (56.5) | 20.4 | (83.9) | (0.4) | (0.1) |
| FINANCING CASH FLOW | |||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 9.5 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.4) | 0 | 1.5 | 54.1 | 313.0 | 14.9 | |||
| Cash From Financing Activities | 1.8 | 8.1 | 71.9 | 393.2 | 313.0 | 14.9 | |||
| CHANGE IN CASH | |||||||||
| Net Change In Cash | 61 K | (33.0) | 5.6 | (203.7) | 232.9 | 8.9 | |||
| FREE CASH FLOW | |||||||||
| Free Cash Flow | (55.7) | (102.7) | (264.8) | (180.0) | (80.4) | (6.1) |